Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00039507 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00039507 is a Phase 2 study that has completed, run by Fox Chase Cancer Center.
The verdict
NCT00039507, a Phase 2 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining radiofrequency ablation with surgery in treating patients who have stage I or stage II non-small cell lung cancer.
Interventions
- PROCEDURE conventional surgery
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-06 |
| Est. Completion | 2004-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00039507
The ClinicalTrials.gov registry entry for NCT00039507 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which conventional surgery is the first listed.
NCT00039507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00039507 about?
NCT00039507 is a clinical study titled "Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer". RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Combining radiofrequency ablation with surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining radiofrequency ablation with surgery in treating patients who have s...
What is the current status of trial NCT00039507?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-06. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00039507?
The interventions under investigation include: conventional surgery (PROCEDURE), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00039507?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.